Takako Nakajima（Principal Investigator）implemented the project（Japan Agency for Medical Research and Development） ‘Evaluation of DEX (steroid) sparing for high emetogenic chemotherapy
Kyoto University
Department of Early Clinical Development
Graduate School of Medicine
Kyoto University Hospital
Department of Early Clinical Development
Kyoto Innovation Center for Next Generation Clinical Trials
and iPS Cell Therapy (Ki-CONNECT)